Your browser doesn't support javascript.
loading
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab.
Tuckwell, Katie; Gabay, Cem; Sornasse, Thierry; Laubender, Ruediger Paul; Wang, Jianmei; Townsend, Michael J.
Affiliation
  • Tuckwell K; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Tuckwell.katie@gene.com.
  • Gabay C; University Hospital of Geneva, Geneva, Switzerland.
  • Sornasse T; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Laubender RP; Roche Diagnostics, Penzberg, Germany.
  • Wang J; Roche Products, Welwyn Garden City, UK.
  • Townsend MJ; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Adv Rheumatol ; 59(1): 54, 2019 12 04.
Article in En | MEDLINE | ID: mdl-31801637
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Intercellular Adhesion Molecule-1 / Chemokine CXCL13 / Antibodies, Monoclonal, Humanized Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Adv Rheumatol Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Intercellular Adhesion Molecule-1 / Chemokine CXCL13 / Antibodies, Monoclonal, Humanized Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Adv Rheumatol Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom